Background: Multiple sclerosis (MS) is a severe and common autoimmune disorder of the central nervous system. Despite the availability of several novel treatment options, the disease is still poorly controlled, since the pathophysiological mechanisms are not fully understood.
Methods: We tested the role of the acid sphingomyelinase/ceramide system in a model of MS, i.